Management of Isolated Right Bundle Branch Block

1. Observation Is Sufficient for Asymptomatic Isolated RBBB

• In patients with isolated right bundle branch block (RBBB) who are asymptomatic and have preserved 1:1 atrioventricular (AV) conduction with a normal PR interval, no medication or permanent pacing is recommended; simple observation is appropriate (ACC/AHA/HRS Class III Harm)【1】.
• Large cohorts show that individuals with isolated fascicular block or isolated RBBB remain completely asymptomatic and require only routine follow‑up without therapeutic intervention【2】.
• Unlike left bundle branch block, isolated RBBB frequently occurs in the absence of structural heart disease or left‑ventricular dysfunction (ACC/AHA/HRS Class III)【3】.

2. Absolute Indications for Permanent Pacing (ACC/AHA/HRS Class I)

• Syncope in the setting of RBBB together with an HV interval ≥ 70 ms, or documented infranodal block on electrophysiology study, mandates permanent pacemaker implantation【1】.
• Alternating bundle‑branch block (switching between LBBB and RBBB morphologies) indicates unstable conduction of both bundles and is an absolute indication for permanent pacing【1】.

3. Reasonable (Class IIa/IIb) Indications for Pacing in Specific Disorders

• In patients with Kearns‑Sayre syndrome who develop any conduction disorder, permanent pacing is considered reasonable (Class IIa)【1】.
• For Anderson‑Fabry disease patients with a QRS duration > 110 ms, pacing may be considered (Class IIb)【1】.

4. Diagnostic Evaluation Pathway

• Confirm isolated RBBB by verifying 1:1 AV conduction and a normal PR interval before any management decision【1】.
• Symptom assessment: screen for syncope, presyncope, or heart‑failure symptoms; presence of symptoms directs further testing (e.g., electrophysiology study)【3】【1】.
• If asymptomatic → continue observation only【1】.
• If syncope is present → perform an electrophysiology study to measure the HV interval and evaluate for infranodal block【1】.

5. Screening for Underlying Conditions That May Necessitate Pacing

• Evaluate for structural heart disease, which can coexist with RBBB and may alter management decisions【3】.
• Identify neuromuscular or infiltrative disorders (e.g., Kearns‑Sayre syndrome, Anderson‑Fabry disease, muscular dystrophies) that carry a higher risk of progressive conduction system disease and may require pacing【1】.

6. Pharmacologic Therapy

• No pharmacologic agents are indicated specifically for isolated RBBB in any clinical scenario (ACC/AHA/HRS Class III)【1】.